Clarity Pharmaceuticals Ltd (CU6.AX)
AUD 2.61
(-3.33%)
AUD 2.61
(-3.33%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -44.8 Million AUD | -23.88% |
| 2023 | -36.16 Million AUD | -19.39% |
| 2022 | -30.29 Million AUD | -124.22% |
| 2021 | -13.5 Million AUD | -37.21% |
| 2020 | -9.84 Million AUD | -53.63% |
| 2019 | -6.4 Million AUD | -52.61% |
| 2018 | -4.19 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -9.09 Million AUD | 51.07% |
| 2024 Q3 | -13.3 Million AUD | 43.68% |
| 2024 FY | -56.3 Million AUD | -55.7% |
| 2024 Q2 | -23.61 Million AUD | -159.55% |
| 2024 Q4 | -13.3 Million AUD | 0.0% |
| 2023 Q4 | -18.59 Million AUD | -156.0% |
| 2023 FY | -36.16 Million AUD | -19.39% |
| 2023 Q3 | -7.26 Million AUD | 58.64% |
| 2023 Q2 | -17.56 Million AUD | -196.88% |
| 2023 Q1 | -5.91 Million AUD | 56.97% |
| 2022 Q1 | -3.47 Million AUD | 52.07% |
| 2022 FY | -30.29 Million AUD | -124.22% |
| 2022 Q4 | -13.75 Million AUD | -172.32% |
| 2022 Q3 | -5.04 Million AUD | 68.21% |
| 2022 Q2 | -15.88 Million AUD | -357.19% |
| 2021 FY | -13.5 Million AUD | -37.21% |
| 2021 Q1 | -2.46 Million AUD | 53.32% |
| 2021 Q4 | -7.24 Million AUD | -169.28% |
| 2021 Q2 | -6.26 Million AUD | -154.0% |
| 2021 Q3 | -2.69 Million AUD | 57.01% |
| 2020 Q1 | -1.68 Million AUD | 0.0% |
| 2020 Q2 | -4.56 Million AUD | -171.79% |
| 2020 Q4 | -5.28 Million AUD | -185.73% |
| 2020 Q3 | -1.84 Million AUD | 59.53% |
| 2020 FY | -9.84 Million AUD | -53.63% |
| 2019 FY | -6.4 Million AUD | -52.61% |
| 2018 FY | -4.19 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Anatara Lifesciences Ltd | -1.45 Million AUD | -2970.374% |
| BTC Health Limited | 1.05 Million AUD | 4345.353% |
| CSL Limited | 5.64 Billion AUD | 100.793% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 191.154% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -1458.945% |
| Orthocell Limited | -11.68 Million AUD | -283.531% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -519.517% |
| Race Oncology Limited | -13.38 Million AUD | -234.819% |
| Starpharma Holdings Limited | -15.15 Million AUD | -195.538% |
| AdAlta Limited | -5.26 Million AUD | -751.466% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -654.445% |
| Memphasys Limited | -2.7 Million AUD | -1556.829% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -2078.427% |
| Acrux Limited | -9.83 Million AUD | -355.569% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -1362.896% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | -204.769% |
| Cynata Therapeutics Limited | -8.8 Million AUD | -408.64% |
| Nyrada Inc. | -4.56 Million AUD | -882.399% |
| PharmAust Limited | -6.65 Million AUD | -572.821% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 5.103% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -522.833% |
| Alterity Therapeutics Limited | -19.6 Million AUD | -128.555% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -912.451% |
| Biome Australia Limited | -1.91 Million AUD | -2241.612% |
| Biotron Limited | -5.15 Million AUD | -769.718% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | -263.947% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 561.075% |
| Immutep Limited | -44.93 Million AUD | 0.303% |
| Imugene Limited | -140.93 Million AUD | 68.211% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -1999.742% |
| Noxopharm Limited | -7.53 Million AUD | -494.567% |
| Patrys Limited | -3.53 Million AUD | -1165.859% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -523.407% |
| PYC Therapeutics Limited | -38.85 Million AUD | -15.296% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | -78.775% |
| Hexima Limited | -1 Million AUD | -4341.205% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 119.827% |
| Nanollose Limited | -1.24 Million AUD | -3484.554% |
| Tissue Repair Ltd | -4.87 Million AUD | -818.809% |
| AnteoTech Limited | -11.72 Million AUD | -282.043% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 31.195% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | -103.166% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -876.222% |
| Actinogen Medical Limited | -12.83 Million AUD | -248.942% |
| Immuron Limited | -5.8 Million AUD | -672.276% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -689.967% |